Morningstar Rating Unlock Stock XNAS Rating as of Feb 16, 2024 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation …5 days ago · Date Requested Open Price Day High Day Low Closing Price Volume Split Adjustment Factor; February 20, 2024: $76.62: $78.00: $76.01: $76.89: 1,136,377: 1:1: February ... Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 …The South San Francisco-based company has attracted interest from at least one major drugmaker in recent months, Bloomberg News reported in October. Shares of Cytokinetics rose as much as 20% in ...Find the historical stock prices of Cytokinetics (CYTK)You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...Interactive stock price chart for Cytokinetics, Incorporated (CYTK) with real-time updates, full price history, technical analysis and more.Real-time Price Updates for Cytokinetics (CYTK-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreCytokinetics Inc share price live 76.89, this page displays NASDAQ CYTK stock exchange data. View the CYTK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cytokinetics Inc real time stock price chart below. You can find more ...The opening auction price ticked up from the premarket to $78.46, on a much higher volume than typical for the last 30 days. The stock showed some weakness ...The stock extended its rally into 2024 despite markets struggling in the new year. ... CYTK Price Action: Shares of Cytokinetics were down 6.48% at $101.06 at the time of publication, ...Stock price history for Cytokinetics (CYTK) Highest end of day price: $108.06 USD on 2024-01-08. Lowest end of day price: $3.07 USD on 2014-10-10. Stock price history of Cytokinetics from 2004 to 2024. Stock price for similar companies or competitors. Company Stock price Change 1d% Country; Amgen. AMGN. $294.43: …According to our current CYTK stock forecast, the value of Cytokinetics shares will drop by -1.11% and reach $ 75.65 per share by February 27, 2024. According to our technical indicators, the current sentiment is Neutral while the Fear & Greed Index is showing 39 (Fear).CYTK stock recorded 14/30 (47%) green days with 7.59% price …Cytokinetics Inc share price live 76.89, this page displays NASDAQ CYTK stock exchange data. View the CYTK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cytokinetics Inc real time stock price chart below. You can find more ...View CYTK price history, and other historical data. Get the latest Cytokinetics Inc (CYTK) stock price, news, analysis, and research in Stockscan.io.Jan 9, 2024 · Bristol Myers Squibb Company (BMY) : Free Stock Analysis Report Cytokinetics, Incorporated (CYTK) : Free Stock Analysis Report AbbVie Inc. (ABBV) : Free Stock Analysis Report Shares of Cytokinetics jumped after The Wall Street Journal reported that Novartis was close to acquiring the company. Shares of Cytokinetics, which is developing a promising heart drug, were ...Complete Cytokinetics Inc. stock information by Barron's. View real-time CYTK stock price and news, along with industry-best analysis. Get the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Cytokinetics to Announce Fourth Quarter Results on February 27, 2024. Globe Newswire • 10 days ago. Track Cytokinetics Inc (CYTK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Morningstar Rating Unlock Stock XNAS Rating as of Feb 16, 2024 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation …Cytokinetics Stock Earnings. The value each CYTK share was expected to gain vs. the value that each CYTK share actually gained. Cytokinetics ( CYTK) reported Q3 2023 earnings per share (EPS) of -$1.35, missing estimates of -$0.74 by 81.36%. In the same quarter last year, Cytokinetics 's earnings per share (EPS) was -$1.52. Cytokinetics (CYTK) reports positive results from its pivotal late-stage study of aficamten in symptomatic obstructive hypertrophic cardiomyopathy patients. The stock rallies 83% in response.See the company profile for Cytokinetics, Incorporated (CYTK) including business summary, ... NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 76.89-1.67 (-2 ...CYTK Cytokinetics · High. 78.000 · Low. 76.010 · Volume. 1.14M · Open. 76.620 · Pre Close. 76.890 · Turnover. 87.30M · Turnover Rat...Jan 16, 2024 ... Cytoknetics shares climbed 9% on the report, from $32.09 to $34.86, only to stay relatively flat in the low- to mid-$30s per share range for a ...Cytokinetics. stock was originally listed at a price of $97.56 in Apr 30, 2004. If you had invested in Cytokinetics stock at $97.56 , your return over the last 19 years would have been -22.52% , for an annualized return of -1.33% (not including any dividends or dividend reinvestments).Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy. Stock split history for Cytokinetics since 2004.CYTK | AI Stock Analysis for Cytokinetics Inc CYTK Including Stock Price, Stock Chart, Technical, Fundamental, Sentiment Analysis and More.The current price Cytokinetics (CYTK) is trading at is $75.80, which is within the analyst’s predicted range. Browse analyst ratings and price targets on all stocks. People Also WatchView Cytokinetics (NASDAQ:CYTK) historical prices, past price performance, and an advanced CYTK stock chart at MarketBeat.What is Cytokinetics Inc(CYTK)'s stock price today? The current price of CYTK is $76.89. The 52 week high of CYTK is $110.25 and 52 week low is $25.98. When is next earnings date of Cytokinetics Inc(CYTK)? The next earnings date of Cytokinetics Inc(CYTK) is 2024-02-27. Does Cytokinetics Inc(CYTK) pay dividends? ...Cytokinetics, Incorporated Common Stock (CYTK) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets.Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.Feb 13, 2024 · Analyst Salim Syed of Mizuho Securities maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price target of $103.00. Salim Syed has given his Buy rating due to a combination ... Jan 16, 2024 · The ups and downs of stock prices are often likened to a roller-coaster ride—and this past month, investors in Cytokinetics (CYTK) have seen all too well the ups, and the downs, of that metaphor ... According to the current price, Cytokinetics is 292.92% away from the 52-week low. What was the 52-week high for Cytokinetics stock? The high in the last 52 weeks of …Apellis Pharmaceuticals Inc. 68.78. +1.20. +1.78%. Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.On eToro, you can buy $CYTK or other stocks and pay ZERO commission! Follow Cytokinetics Inc share price and get more information. Terms apply.Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. Jan 12, 2024 · Shares of Cytokinetics plummeted further Thursday after the Journal reported that Novartis has backed away from a deal to acquire the heart-drug developer. Cytokinetics stock was recently down 24%. Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing.Analyst Salim Syed of Mizuho Securities maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price target of $103.00. Salim Syed has given his Buy rating due to a combination ...Get Cytokinetics Inc (CYTK.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsHow Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it looks to take on Bristol in heart disease.The average Cytokinetics stock price prediction forecasts a potential upside of 10.28% from the current CYTK share price of $75.59. What is CYTK's forecast ...Cytokinetics CYTK shares rallied 11.4% in the last trading session to close at $30.60.This move can be attributable to notable volume with a higher number of shares being traded than in a typical ...57,973.31 -165.23(-0.28%) Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Add to watchlist 81.87 +0.62 (+0.76%) At close: …Cytokinetics, Incorporated (KK3A.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | Deutsche Boerse ...Cytokinetics Stock Earnings. The value each CYTK share was expected to gain vs. the value that each CYTK share actually gained. Cytokinetics ( CYTK) reported Q3 2023 earnings per share (EPS) of -$1.35, missing estimates of -$0.74 by 81.36%. In the same quarter last year, Cytokinetics 's earnings per share (EPS) was -$1.52. With Cytokinetics stock trading at $84.12 per share, the total value of Cytokinetics stock (market capitalization) is $8.25B. Cytokinetics stock was originally …Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 81.87 +0.62 (+0.76%) At close: 04:00PM EST. 79.95 -1.92 ( …ugurhan. Morgan Stanley downgraded its rating of Cytokinetics (NASDAQ:CYTK) to equal weight, but raised its price target, stating it saw the shares approaching full valuation.The investment bank ...4 days ago · Cytokinetics (CYTK) Stock Price, News & Analysis $76.50 -0.39 (-0.51%) (As of 02/21/2024 ET) Compare Today's Range $75.66 $77.35 50-Day Range $35.72 $108.06 52-Week Range $25.98 $110.25 Volume 974,122 shs Average Volume 3.94 million shs Market Capitalization $7.50 billion P/E Ratio N/A Dividend Yield N/A Price Target $73.94 32.87M. AAPL. 182.12. -0.95%. 48.33M. View today's Cytokinetics Inc stock price and latest CYTK news and analysis. Create real-time notifications to follow any changes in the live stock price.-1.67 -2.13% Healthcare • Biotechnology • USA • NASD Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert Draw Ideas Candle - …Cytokinetics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.Get Cytokinetics Inc (CYTK.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsMaintaining a Buy rating and a price target of $50, Choi concludes that Cytokinetics represents an attractive investment opportunity based on the upcoming catalysts and its long-term market potential.Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference; The biotech stocks to own in 2024, according to Piper Sandler; Cytokinetics price target raised to $78 from $48 at ...Stock Quote. Stock Information. Stock Quote; Stock Chart; Historical Price Lookup ... posters and/or oral presentations that contain data from Cytokinetics-sponsored ... NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 76.89-1.67 (-2.13%) ... Cytokinetics, Incorporated has a strategic alliance with Astellas Pharma Inc. The ... A high-level overview of Cytokinetics, Incorporated (CYTK) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Cytokinetics has risen higher in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%. Is Cytokinetics Stock Undervalued? The current Cytokinetics [ CYTK] share price is $76.89. The Score for CYTK is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.The stock extended its rally into 2024 despite markets struggling in the new year. ... CYTK Price Action: Shares of Cytokinetics were down 6.48% at $101.06 at the time of publication, ...The South San Francisco-based company has attracted interest from at least one major drugmaker in recent months, Bloomberg News reported in October. Shares of Cytokinetics rose as much as 20% in ...Dec 27, 2023 · Get the latest Cytokinetics Incorporated (CYTK) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Dec 31, 2022. -299,516. -296,741. Item. Description. The company. FCFF. Free cash flow to the firm is the cash flow available to the Cytokinetics Inc. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made. Cytokinetics Inc. FCFF decreased from 2020 to 2021 and from ...Cytokinetics (CYTK) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. CYTK Cytokinetics · High. 79.590 · Low. 76.780 · Volume. 1.32M · Open. 78.460 · Pre Close. 78.560 · Turnover. 102.80M · Turnover Ra...Cytokinetics stock is now considered extended and out of buy range after clearing a 47.90 buy point in a first-stage consolidation. ... Fed Minutes: Stock Prices Becoming An Inflation Threat; ...The lead drug for Cytokinetics is omecamtiv which is being developed in partnership with Amgen for the treatment of chronic heart failure, a quite different indication. We are expecting phase 3 results from a huge 8,000 patient trial in 4Q, 2020. Cytokinetics is also developing CK-274 which is a direct competitor and fast follower to mavacamten.You can buy or sell Cytokinetics and other ETFs, options, and stocks. View the real-time CYTK price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule ...What this means: Cytokinetics (CYTK) gets an Overall Rank of 64, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.Check the Cytokinetics stock price today on the NASDAQ stock exchange and access historical CYTK stock price chart. Get the latest Cytokinetics stock ...Cytokinetics’ share price fell 16% yesterday on news that Novartis has dropped its pursuit of the biotech. ... One problem for potential buyers is the phase 3 data sent the stock into overdrive.Cytokinetics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.Cytokinetics, Incorporated (KK3A.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | BOERSE MUENCHEN ...Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...Complete Cytokinetics Inc. stock information by Barron's. View real-time CYTK stock price and news, along with industry-best analysis.1 Data adjusted for splits and stock dividends. 2 2022 Calculation Operating profit per share = Operating loss ÷ No. shares of common stock outstanding = -324,202,000 ÷ 95,161,391 = -3.41. 3 Closing price as at the filing date of Cytokinetics Inc. Annual Report. 4 2022 Calculation P/OP ratio = Share price ÷ Operating profit per share = 43.11 ...According to 16 analysts, the average rating for CYTK stock is "Strong Buy." The 12-month stock price forecast is $75.31, which is a decrease of -0.37% from the …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a br...Analyst Salim Syed of Mizuho Securities maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price target of $103.00. Salim Syed has given his Buy rating due to a combination ...On eToro, you can buy $CYTK or other stocks and pay ZERO commission! Follow Cytokinetics Inc share price and get more information. Terms apply.Jan 8, 2024 · How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. 2/09/2024 Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it looks to take ... Cytokinetics, Incorporated (KK3A.FRA) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | Deutsche Boerse ...Analyst Salim Syed of Mizuho Securities maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price target of $103.00. Salim Syed has given his Buy rating due to a combination ...Stock Price Forecast. The 17 analysts with 12-month price forecasts for Cytokinetics stock have an average target of 73.76, with a low estimate of 49 and a high ...Cytokinetics Stock Performance (As of Tuesday Closing) Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $84.80: $83.69: $25.98 - $110.25: $8.31B: 98.1M: 3.63M-$5.52: Cytokinetics Financials Summary. In Thousands, USD TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021Cytokinetics stock price
CYTK stock tacked on another 15%-plus on Jan. 8 when a rumor suggested Novartis could be entertaining a buyout bid for Cytokinetics. That put CYTK stock's gain at more than 141% over two weeks.Update 11:30 AM EST: Adds latest share price move and reaction from EWTX. Cytokinetics (NASDAQ:CYTK) shares hit a 52-week high on Wednesday after the biotech posted encouraging data from a pivotal ...SOUTH SAN FRANCISCO, Calif., July 16, 2020 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced the pricing of an underwritten public offering of 7,291,667 shares of its common stock at a price to the public of $24.00 per share, before underwriting discounts and commissions. The gross proceeds to …Shares of Cytokinetics plummeted further Thursday after the Journal reported that Novartis has backed away from a deal to acquire the heart-drug developer. Cytokinetics stock was recently down 24%.View real-time Cytokinetics Inc (CYTK) share prices and assess historical data, charts, technical analysis, performance reports and NASDAQ CYTK share chat forum. ... Use the dropdown to select a relevant stock exchange for the current NASDAQ CYTK share price (ISIN: US23282W6057) to enhance your trading decisions with our free resources. Day's ...See the company profile for Cytokinetics, Incorporated (CYTK) including business summary, ... NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 76.89-1.67 (-2 ...Stock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...Their CYTK share price targets range from $42.00 to $108.00. On average, they anticipate the company's stock price to reach $73.94 in the next twelve months. …B.Riley Financial analyst Mayank Mamtani reiterated a Buy rating on Cytokinetics (CYTK – Research Report) yesterday and set a price target of $122.00. Mayank Mamtani’s Buy rating is based on ...Dec 27, 2023 · The shares rose as much as 83% at the New York market open, the most intraday since they began trading in 2004. Cytokinetics had a market value of more than $4.4 billion before the surge, and ... 182.12. -0.95%. 48.33M. View today's Cytokinetics Inc stock price and latest CYTK news and analysis. Create real-time notifications to follow any changes in the live stock price. Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. B. Riley started coverage on Cytokinetics in a research report on Tuesday, November 7th. They set a "buy" rating and a $66.00 target price on the stock. UBS …The ups and downs of stock prices are often likened to a roller-coaster ride—and this past month, investors in Cytokinetics (CYTK) have seen all too well the ups, and the downs, of that metaphor ...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Dec 28, 2023 ... Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and ...Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 81.87 +0.62 (+0.76%) At close: 04:00PM EST. 79.95 -1.92 ( …Stock split history for Cytokinetics (CYTK) Cytokinetics stock (symbol: CYTK) underwent a total of 1 stock split. The stock split occured on June 25th, 2013. One CYTK share bought prior to June 25th, 2013 would equal to …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...Cytokinetics Stock Performance (As of Tuesday Closing) Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $84.80: $83.69: $25.98 - $110.25: $8.31B: 98.1M: 3.63M-$5.52: Cytokinetics Financials Summary. In Thousands, USD TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...The stock price for . Cytokinetics (NASDAQ: CYTK) is $75.8 last updated February 22, 2024 at 6:11 PM EST. Q. Does Cytokinetics (CYTK) pay a dividend? A. There are no upcoming dividends for ...View Cytokinetics (NASDAQ:CYTK) historical prices, past price performance, and an advanced CYTK stock chart at MarketBeat.Cytokinetics shares skyrocketed to a 19-year high, advancing more than 80% in late Wednesday trading to about $82.50. Cytokinetics Inc. reported positive results Wednesday from a key Phase 3 study ...Dec 27, 2023 · The stock has run up 62.8% year to date, while the iShares Biotechnology exchange-traded fund IBB has gained 3.4% and the S&P 500 SPX has advanced 24.5%. Advertisement Partner Center Dec 31, 2022. -299,516. -296,741. Item. Description. The company. FCFF. Free cash flow to the firm is the cash flow available to the Cytokinetics Inc. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made. Cytokinetics Inc. FCFF decreased from 2020 to 2021 and from ...The opening auction price ticked up from the premarket to $78.46, on a much higher volume than typical for the last 30 days. The stock showed some weakness ...Cytokinetics (CYTK – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. ... UBS also downgraded the stock to a Hold with a $92.00 price target ...Cytokinetics, Inc. Wednesday announced positive results from SEQUOIA-HCM, the pivotal Phase 3 clinical trial of Aficamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.In the pre-market session, the shares are at $70.02, up 53.69 percent from its previous close of $45.71. The results of SEQUOIA-HCM showed that …CYTK Stock 12 Months Forecast. $92.00. (11.52% Upside) Based on 17 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The average price target is $92.00 with a high forecast of $122.00 and a low forecast of $54.00. The average price target represents a 11.52% change from the last price of $82.50.Published: Dec. 27, 2023 at 7:43 a.m. ET. By Denny Jacob. Cytokinetics shares surged 42% to $65 in premarket trading after announcing positive topline results from a trial of aficamten in patients ... 4 days ago · Cytokinetics (CYTK) Stock Price, News & Analysis $76.50 -0.39 (-0.51%) (As of 02/21/2024 ET) Compare Today's Range $75.66 $77.35 50-Day Range $35.72 $108.06 52-Week Range $25.98 $110.25 Volume 974,122 shs Average Volume 3.94 million shs Market Capitalization $7.50 billion P/E Ratio N/A Dividend Yield N/A Price Target $73.94 Published: Dec. 27, 2023 at 7:43 a.m. ET. By Denny Jacob. Cytokinetics shares surged 42% to $65 in premarket trading after announcing positive topline results from a trial of aficamten in patients ... Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real-time price. Currency in USD. Add to watchlist. 81.87 +0.62 (+0.76%) At close: 04:00PM EST. 79.95 -1.92 ( …MT. UBS Downgrades Cytokinetics to Neutral From Buy, Adjusts Price Target to $92 From $61. Jan. 24. MT. Mizuho Securities Boosts Price Target on Cytokinetics to $103 From $80, Keeps Buy Rating. Jan. 19. MT. Cytokinetics Insider Sold Shares Worth $425,700, According to a Recent SEC Filing. Jan. 12. Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy. Stock split history for Cytokinetics since 2004.Jan 12, 2024 · What is the support and resistance for Cytokinetics (CYTK) stock price? CYTK support price is $34.79 and resistance is $37.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability ... The opening auction price ticked up from the premarket to $78.46, on a much higher volume than typical for the last 30 days. The stock showed some weakness ...Company profile for Cytokinetics, Incorporated (CYTK) with a description, list of executives, contact details and other key facts. ... Stock Analysis Pro. Watchlist. Collapse. Cytokinetics, Incorporated (CYTK) NASDAQ: CYTK · IEX Real-Time Price · USD. Add to Watchlist 76.89-1.67 (-2.13%) At close: Feb 16, 2024, 4:00 PM. 77.10 +0.21 …Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods th...CYTK Cytokinetics · High. 79.590 · Low. 76.780 · Volume. 1.32M · Open. 78.460 · Pre Close. 78.560 · Turnover. 102.80M · Turnover Ra...Dec 28, 2023 ... Cytokinetics (CYTK) ... Real-time quote and/or trade prices are not sourced from all markets. The biotech company showed 0% earnings growth in its ...Get the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Stock analysis for Cytokinetics Inc (CYTK:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.In depth view into CYTK (Cytokinetics) stock including the latest price, news, dividend history, earnings information and financials. Cytokinetics Inc (CYTK) 76.89 -1.67 ( -2.13% ) USD | NASDAQ | Feb 16, 16:00If you need cash, aren’t happy with your investment returns or want to diversify your investments, you may have to liquidate some of your stocks. Buying and selling stocks is extre...Since its IPO on the Shenzhen stock exchange, its share price has gone up every day by the exact same amount. Baofeng Technologies is China’s best performing stock this year. Since...Cytokinetics Stock Earnings. The value each CYTK share was expected to gain vs. the value that each CYTK share actually gained. Cytokinetics ( CYTK) reported Q3 2023 earnings per share (EPS) of -$1.35, missing estimates of -$0.74 by 81.36%. In the same quarter last year, Cytokinetics 's earnings per share (EPS) was -$1.52. Cytokinetics, Incorporated (KK3A.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Cytokinetics, Incorporated | BOERSE MUENCHEN ...View Cytokinetics (CYTK) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the ...Cytokinetics Inc stock is currently priced at $76.89, with a 24-hour trading volume of 1.32M. It has seen a -2.13% decreased in the last 24 hours and a -5.30% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $77.77 pivot point. If it approaches the $76.83 support level, significant changes may ...According to Accountingbase.com, common stock is neither an asset nor a liability; it is considered equity. Equity is basically considered to mathematically be the difference betwe...-61.55(-0.16%) -77.25 Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 76.62 -0.27 (-0.35%) As of 11:08AM …On top of that, the share price is up 129% in about a quarter. ... Of course Cytokinetics may not be the best stock to buy. So you may wish to see this free collection of growth stocks.NEW YORK (AP) — Stocks that are trading heavily or have substantial price changes on Wednesday: Cytokinetics Inc. (CYTK), up $37.74 to $83.45. The biopharmaceutical company gave investors an encouraging update on the development of a potential heart condition treatment. Coherus BioSciences Inc. (CHRS), up 51 cents to …For more than 25 years, Cytokinetics, a late-stage biopharmaceutical company, has been finding strength in science as a pioneer in the field of muscle biology working to discover, develop, and commercialize potential medicines that may preserve and extend independence in people suffering from debilitating diseases. See our story.Published: Dec. 27, 2023 at 7:43 a.m. ET. By Denny Jacob. Cytokinetics shares surged 42% to $65 in premarket trading after announcing positive topline results from a trial of aficamten in patients ... 3 days ago · Stock Price Forecast. The 17 analysts with 12-month price forecasts for Cytokinetics stock have an average target of 73.76, with a low estimate of 49 and a high estimate of 108. The average target predicts a decrease of -5.94% from the current stock price of 78.42. How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it looks to take on Bristol in heart disease.Company profile for Cytokinetics, Incorporated (CYTK) with a description, list of executives, contact details and other key facts. ... Stock Analysis Pro. Watchlist. Collapse. Cytokinetics, Incorporated (CYTK) NASDAQ: CYTK · IEX Real-Time Price · USD. Add to Watchlist 76.89-1.67 (-2.13%) At close: Feb 16, 2024, 4:00 PM. 77.10 +0.21 …-64.19(-0.17%) Nasdaq -144.87(-0.92%) Russell 2000 -28.60(-1.41%) -0.92(-1.16%) Gold +11.60(+0.57%) Cytokinetics, Incorporated (CYTK) NasdaqGS - NasdaqGS Real Time …CYTK) stock’s latest price update. Cytokinetics Inc (NASDAQ: CYTK) has seen a decline in its stock price by -1.19 in relation to its previous close of 76.50. However, the company has experienced a -1.19% decline in its stock price over the last five trading sessions. GlobeNewsWireJan 9, 2024 · Shares of Cytokinetics, Incorporated (CYTK Quick Quote CYTK - Free Report) ... This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating ... ugurhan. Morgan Stanley downgraded its rating of Cytokinetics (NASDAQ:CYTK) to equal weight, but raised its price target, stating it saw the shares approaching full valuation.The investment bank ...CYTK Stock 12 Months Forecast. $92.00. (11.52% Upside) Based on 17 Wall Street analysts offering 12 month price targets for Cytokinetics in the last 3 months. The average price target is $92.00 with a high forecast of $122.00 and a low forecast of $54.00. The average price target represents a 11.52% change from the last price of $82.50.The last closing price for Cytokinetics was $78.56. Over the last year, Cytokinetics shares have traded in a share price range of $ 25.98 to $ 110.25. Cytokinetics currently has 98,053,647 shares ...Cytokinetics has a market cap or net worth of $7.56 billion as of February 7, 2024. Its market cap has increased by 94.62% in one year. Market Cap ... Formula: Market Cap = Stock Price * Shares Outstanding. Full Definition. Related Stocks. Company Market Cap; ImmunoGen: 8.19B: Ascendis Pharma: 8.09B: Apellis Pharmaceuticals: 8.08B ...On top of that, the share price is up 129% in about a quarter. ... Of course Cytokinetics may not be the best stock to buy. So you may wish to see this free collection of growth stocks.Jan 9, 2024 · Shares of Cytokinetics, Incorporated (CYTK Quick Quote CYTK - Free Report) ... This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating ... -1.67 -2.13% Healthcare • Biotechnology • USA • NASD Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert Draw Ideas Candle - …The lead drug for Cytokinetics is omecamtiv which is being developed in partnership with Amgen for the treatment of chronic heart failure, a quite different indication. We are expecting phase 3 results from a huge 8,000 patient trial in 4Q, 2020. Cytokinetics is also developing CK-274 which is a direct competitor and fast follower to mavacamten.The Cytokinetics stock forecast for tomorrow is $ 76.52, which would represent a 0.03% gain compared to the current price. In the next week, the price of CYTK is expected to decrease by -1.11% and hit $ 75.65. As far as the long-term Cytokinetics stock forecast is concerned, here’s what our ... In another report released on October 30, J.P. Morgan also maintained a Buy rating on the stock with a $48.00 price target. ... Cytokinetics price target lowered to $48 from $54 at JPMorgan;. Directions to appleton wisconsin